SoluMatrix® Diclofenac: Sustained Opioid-Sparing Effects in a Phase 3 Study in Patients with Postoperative Pain.
about
SoluMatrix® Diclofenac: Sustained Opioid-Sparing Effects in a Phase 3 Study in Patients with Postoperative Pain.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
SoluMatrix® Diclofenac: Sustai ...... ients with Postoperative Pain.
@en
SoluMatrix® Diclofenac: Sustai ...... ients with Postoperative Pain.
@nl
type
label
SoluMatrix® Diclofenac: Sustai ...... ients with Postoperative Pain.
@en
SoluMatrix® Diclofenac: Sustai ...... ients with Postoperative Pain.
@nl
prefLabel
SoluMatrix® Diclofenac: Sustai ...... ients with Postoperative Pain.
@en
SoluMatrix® Diclofenac: Sustai ...... ients with Postoperative Pain.
@nl
P2093
P2860
P356
P1433
P1476
SoluMatrix® Diclofenac: Sustai ...... ients with Postoperative Pain.
@en
P2093
Bill McCarberg
Charles Argoff
Clarence Young
Jeff Gudin
Srinivas Nalamachu
P2860
P304
P356
10.1093/PM/PNW012
P577
2016-03-19T00:00:00Z